Orphazyme A/S
HEAT SHOCK PROTEIN INDUCERS AND FRONTOTEMPORAL DISORDERS
Last updated:
Abstract:
The present invention relates to a bioactive agent that increases the intracellular concentration and/or activity of one or more heat shock proteins, including Hsp70, for use in the treatment of frontotemporal disorders.
Status:
Application
Type:
Utility
Filling date:
24 May 2018
Issue date:
19 Mar 2020